Mannitol injections: with or without filter needles? A cost-effectiveness analysis

Area of Science:

• Clinical Economics
• Pharmacoeconomics
• Healthcare Management

Background:

• Intravenous (i.v.) mannitol injections are used in various clinical settings.
• Particulate contamination in injectable medications can pose risks to patients.
• The necessity of filtration for specific i.v. drug administrations requires economic justification.

Purpose of the Study:

• To perform a clinical economic evaluation of using filter needles for i.v. mannitol injections.
• To assess the cost-effectiveness of filtering undiluted, i.v. push mannitol 25% solutions.

Main Methods:

• A clinical decision analysis model was employed to evaluate costs and benefits.
• Sensitivity analysis was performed by varying uncertain variables to determine the robustness of the findings.
• The study focused on undiluted, i.v. push administrations of mannitol 25%.

Main Results:

• The use of filter needles for i.v. mannitol injections was found to be a cost-effective measure.
• Sensitivity analysis confirmed cost-effectiveness across all tested best-case and worst-case scenarios.
• Filtration of mannitol injections represents a valuable clinical intervention.

Conclusions:

• Filtration of i.v. mannitol injections using filter needles is a clinically and economically sound practice.
• The implementation of filter needles enhances patient safety without compromising economic viability.
• This evaluation supports the routine use of filter needles for specific mannitol administrations.